» Authors » Qiwei Ren

Qiwei Ren

Explore the profile of Qiwei Ren including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 47
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang J, Jiang T, Wang X, Zhao M, Shi H, Zhang H, et al.
Alzheimers Dement . 2025 Jan; 21(2):e14506. PMID: 39868480
Introduction: Malnutrition correlates with neuropsychiatric symptoms (NPSs) in Alzheimer's disease (AD); however, the potential mechanism underlying this association remains unclear. Methods: Baseline and longitudinal associations of nutritional status with NPSs...
2.
Wang L, Jiang J, Wang Y, Liu G, Li W, Ren Q, et al.
Aging Med (Milton) . 2025 Jan; 7(6):744-753. PMID: 39777092
Objectives: To outline the design of the P3 study and serve as a summary of the interim baseline patient characteristics. Methods: P3 study is a multicenter, prospective cohort study targeting...
3.
Wang X, Wang Y, Jiang T, Jiang J, Wang L, Yang S, et al.
Genes Dis . 2024 Dec; 12(2):101289. PMID: 39669550
No abstract available.
4.
Jiang J, Zhao K, Li W, Zheng P, Jiang S, Ren Q, et al.
Biol Psychiatry . 2024 Oct; PMID: 39419461
Background: The high heterogeneity of neuropsychiatric symptoms (NPSs) hinders further exploration of their role in neurobiological mechanisms and Alzheimer's disease (AD). We aimed to delineate NPS patterns based on brain...
5.
Jiang J, Zhuo Z, Wang A, Li W, Jiang S, Duan Y, et al.
Alzheimers Res Ther . 2024 Jul; 16(1):149. PMID: 38961406
Background: Enlarged choroid plexus (ChP) volume has been reported in patients with Alzheimer's disease (AD) and inversely correlated with cognitive performance. However, its clinical diagnostic and predictive value, and mechanisms...
6.
Li R, Zhuo Z, Hong Y, Yao Z, Li Z, Wang Y, et al.
J Magn Reson Imaging . 2024 Mar; 60(5):2173-2183. PMID: 38544434
Background: The fasting-postprandial state remains an underrecognized confounding factor for quantifying cerebral blood flow (CBF) in the cognitive assessment and differential diagnosis of Alzheimer's disease (AD). Purpose: To investigate the...
7.
Jiang J, Hong Y, Li W, Wang A, Jiang S, Jiang T, et al.
J Alzheimers Dis . 2023 Oct; 96(2):669-681. PMID: 37840496
Background: Apolipoprotein E (APOE) is the most recognized risk gene for cognitive decline and clinical progression of late-onset Alzheimer's disease (AD); nonetheless, its association with neuropsychiatric symptoms (NPSs) remains inconclusive....
8.
Bai C, Ren Q, Liu H, Li X, Guan W, Gao Y
Front Cell Dev Biol . 2023 Aug; 11:1258178. PMID: 37601100
[This corrects the article DOI: 10.3389/fcell.2021.673231.].
9.
Jiang J, Shi H, Jiang S, Wang A, Zou X, Wang Y, et al.
Sci China Life Sci . 2023 Apr; 66(10):2257-2279. PMID: 37058185
Alzheimer's disease (AD) is the leading cause of dementia in older individuals and is an escalating challenge to global public health. Pharmacy therapy of AD is one of the well-funded...
10.
Bai C, Ren Q, Liu H, Li X, Guan W, Gao Y
Front Cell Dev Biol . 2021 May; 9:673231. PMID: 34055806
Conclusion: This study describes a novel approach for beta cell production and supports the use of iPSCs for cell replacement therapy of T1DM.